Taken together, the in vivo and in vitro results demonstrate that the loss of p300 enhanced the self-renewal and proliferation of Tet2-deficient HSPCs, increasing the bone marrow HSPC pool and accelerating leukemia development of the doubly deficient mice. The gene discussed is TET2; the disease is leukemia.